22 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33376542 | Inhibition of autophagy enhances apoptosis induced by bortezomib in AML cells. | 2021 Feb | 1 |
2 | 34025442 | Proteasome Inhibition Suppresses KIT-Independent Gastrointestinal Stromal Tumors Via Targeting Hippo/YAP/Cyclin D1 Signaling. | 2021 | 1 |
3 | 29057477 | The MIP-1α autocrine loop contributes to decreased sensitivity to anticancer drugs. | 2018 May | 2 |
4 | 26423802 | Endoplasmic reticulum stress and autophagy participate in apoptosis induced by bortezomib in cervical cancer cells. | 2016 Feb | 1 |
5 | 25686825 | NF-κB signaling mediates acquired resistance after PARP inhibition. | 2015 Feb 28 | 2 |
6 | 25812695 | Mcl-1 downregulation sensitizes glioma to bortezomib-induced apoptosis. | 2015 May | 1 |
7 | 23079083 | Bortezomib/proteasome inhibitor triggers both apoptosis and autophagy-dependent pathways in melanoma cells. | 2013 Jan | 2 |
8 | 23698252 | Bortezomid enhances the efficacy of lidamycin against human multiple myeloma cells. | 2013 Jul | 1 |
9 | 22313636 | Bortezomib induces apoptosis and growth suppression in human medulloblastoma cells, associated with inhibition of AKT and NF-ĸB signaling, and synergizes with an ERK inhibitor. | 2012 Apr | 1 |
10 | 23226303 | Bortezomib is cytotoxic to the human growth plate and permanently impairs bone growth in young mice. | 2012 | 2 |
11 | 19139079 | CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy. | 2009 Apr 30 | 2 |
12 | 20193325 | [Apoptosis in Jurkat cells induced by bortezomib combined with adriamycin]. | 2009 Dec | 2 |
13 | 20495713 | Proteasome inhibition enhances antitumour effects of gemcitabine in experimental pancreatic cancer. | 2009 Nov | 2 |
14 | 17653083 | A pivotal role for Mcl-1 in Bortezomib-induced apoptosis. | 2008 Jan 31 | 1 |
15 | 18223318 | Proteasome inhibitor Bortezomib induces cell cycle arrest and apoptosis in cell lines derived from Ewing's sarcoma family of tumors and synergizes with TRAIL. | 2008 Apr | 1 |
16 | 18316628 | Dual targeting of the proteasome regulates survival and homing in Waldenstrom macroglobulinemia. | 2008 May 1 | 1 |
17 | 17786311 | The mechanism of cross-resistance to proteasome inhibitor bortezomib and overcoming resistance in Ewing's family tumor cells. | 2007 Oct | 1 |
18 | 17898295 | The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro. | 2007 Oct | 2 |
19 | 17156654 | [Apoptosis of myeloid leukemia cell line HL60 induced by Bortezomib, a proteasome inhibitor]. | 2006 Sep 12 | 1 |
20 | 15609327 | Bortezomib is an efficient agent in plasma cell leukemias. | 2005 Apr 20 | 1 |
21 | 12893773 | The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl+ cells sensitive and resistant to STI571. | 2003 Nov 15 | 1 |
22 | 11350913 | Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma. | 2001 May | 1 |